ALN-5288
ALN-5288-001
Phase 1 small_molecule active
Quick answer
ALN-5288 for Alzheimer's Disease is a Phase 1 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Alzheimer's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active